Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain

European Journal of Pharmacology

Volumn 366, Issue 1, 1999, Pages 41-45

  Xu, Mei ^a   Kontinen, Vesa K ^a   Kalso, Eija ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

2 Adrenoceptor antagonist; Allodynia; Animal model; Atipamezole; Neuropathic pain

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; NALOXONE;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRATHECAL DRUG ADMINISTRATION; MALE; NERVE LIGATION; NEURALGIA; NOCICEPTION; NONHUMAN; NORADRENERGIC SYSTEM; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT; SPINAL NERVE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; IMIDAZOLES; LIGATION; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; SODIUM CHLORIDE; SPINAL NERVES;

EID: 0032980832     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00910-8     Document Type: Article

References (27)

1. Arnér, S., Meyerson, B.A., 1988. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11-23.
2. Altal, N., Kayser, V., Guilbaud, G., 1990. The bidirectional dose-dependent effect of systemic naloxone is also related to the intensity and duration of pain-related disorders: a study in a rat model of peripheral mononeuropathy. Brain Res. 525, 170-174.
3. Bennett, G.J., Xie, Y.K., 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87-107.
4. Bian, D., Nichols, M.L., Ossipov, M.H., Lai, J., Porreca, F., 1995. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. Neuro Report 6, 1981-1984.
5. Choi, Y., Yoon, Y.W., Na, U.S., Kim, S.H., Chung, J.M., 1994. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59, 369-376.
6. Devor, M., 1983. Nerve pathophysiology and mechanisms of pain in causalgia. J. Auton. Nerv. Sys. 7, 371-384.
7. Dubner, R., Max, M., 1992. Antidepressants and relief of neuropathic pain: evidence for noradrenergic mechanisms. In: Besson, J.-M., Guilbaud, G. (Eds.), Noradrenergic Agonists for the Treatment of Pain, Excerpta Medica, Amsterdam, pp. 211-218.
8. Jänig, W., McLachlan, E.M., 1994. The role of modifications in noradrenergic peripheral pathways after nerve lesions in the generation of pain. In: Fields, H.L., Liebeskind, J.C. (Eds.), Progress in Pain Research and Management, IASP Press, Seattle.
9. Kim, S.H., Chung, J.M., 1991. Sympathectomy alleviates mechanical allodynia in an experimental animal model for neuropathy in the rat. Neurosci. Lett. 134, 131-134.
10. Kim, S.H., Chung, J.M., 1992. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355-363.
11. Kim, S.H., Na, H.S., Sheen, K., Chung, J.M., 1993. Effects of sympathectomy on a rat model of peripheral neuropathy. Pain 55, 85-92.
12. Kim, K.J., Yoon, Y.W., Chung, J.M., 1997. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 113, 200-206.
13. 2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF. Peptides 16, 973-977.
14. Kontinen, V.K., Paananen, S., Kalso, E.A., 1998a. Effects of systemic morphine in the spinal nerve ligation model of neuropathic pain in rats. Eur. J. Pain 2, 35-42.
15. 2-adrenergic agonist, dexmedetomidine, in the rat spinal nerve ligation model of neuropathic pain in rats. Anesth. Analg. 86, 355-360.
16. Lee, B.H., Yoon, Y.W., Chung, K., Chung, J.M., 1998. Comparison of sympathetic sprouting in sensory ganglia in three animal models of neuropathic pain. Exp. Brain Res. 120, 432-438.
17. Lee, Y.W., Chaplan, S.R., Yaksh, T.L., 1995. Systemic and supraspinal, but not spinal, opiates supress allodynia in a rat neuropathic pain model. Neurosci. Lett. 186, 111-114.
18. Nichols, M.L., Bian, D., Ossipov, H., Lai, J., Porreca, F., 1995. Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain on rats. J. Pharmacol. Exp. Ther. 275, 1339-1345.
19. Ren, K., Dubner, R., 1993. NMDA receptor antagonists attenuate mechanical hyperalgesia in rat with unilateral inflammation of the hindpaw. Neurosci. Lett. 163, 22-26.
20. Richards, R.L., 1967. Causalgia. Arch. Neurol. 16, 339-350.
21. Seltzer, Z., Dubner, R., Shir, Y., 1990. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43, 205-218.
22. Xu, X.J., Hao, J.X., Seiger, A., Hughes, J., Hökfelt, T., Wiesenfeld-Hallin, Z., 1994. Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain 56, 271-277.
23. Yaksh, T.L., Rudy, T.A., 1976. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17, 1031-1036.
24. 2-adrenoceptor agonists. J. Pharmacol. Exp. Ther. 272, 207-214.
25. Yamamoto, T., Nozaki-Taguchi, N., 1996. Clonidine, but not morphine, delays the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat. Anesthesiology 85, 835-845.
26. Yu, W., Xu, X.J., Hao, J.X., Wiesenfeld-Hallin, Z., 1997. Comparison of the antiallodynic and antinociceptive effects of systemic, intrathecal and intracerebroventricular morphine in a rat model of central neuropathic pain. Eur. J. Pain 1, 17-29.
27. Zimmermann, M., 1983. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 16, 109-110.